☆ 4.7 Article

Development of humoral and cellular immunological memory against SARS-CoV-2 despite B cell depleting treatment in multiple sclerosis

ISCIENCE (2021)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Clinical Neurology

Disease-Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis

Maria P. Sormani et al.

Summary: This study assessed the impact of immunosuppressive and immunomodulatory therapies on the severity of COVID-19 in people with multiple sclerosis. Therapy with an anti-CD20 agent and recent use of methylprednisolone were associated with increased risk of severe COVID-19.

ANNALS OF NEUROLOGY (2021)

添加到收藏夹

Article Immunology

High seroprevalence but short-lived immune response to SARS-CoV-2 infection in Paris

Francois Anna et al.

Summary: This study conducted in Paris conurbation found that the prevalence of SARS-CoV-2 infection in active workers was approximately 11.6% in May-July 2020, higher than laboratory testing positivity rates. The research also indicated that some infected individuals did not exhibit systemic IgG responses, suggesting that the true infection rate may have reached 16.6%, with anosmia and ageusia being common symptoms of infection.

EUROPEAN JOURNAL OF IMMUNOLOGY (2021)

添加到收藏夹

Editorial Material Immunology

T Cell Memory: Understanding COVID-19

Nicholas N. Jarjour et al.

Summary: This primer discusses the fundamental features of T cell memory and their potential relevance for effective immunity to SARS-CoV-2, as the focus shifts towards establishing natural and vaccine-induced immunity against COVID-19.

IMMUNITY (2021)

添加到收藏夹

Review Medicine, General & Internal

Current and emerging disease-modulatory therapies and treatment targets for multiple sclerosis

F. Piehl

Summary: Treatment of multiple sclerosis is evolving with the approval of novel and increasingly effective disease-modulatory therapies. In clinical development, inhibitors of Bruton's tyrosine kinase represent a new emerging drug class in MS. Accumulating evidence suggests the importance of early high effective therapy while maintaining acceptable tolerability.

JOURNAL OF INTERNAL MEDICINE (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Correlates of protection against SARS-CoV-2 in rhesus macaques

Katherine McMahan et al.

Summary: Adoptive transfer of purified IgG from convalescent macaques protects naive macaques against SARS-CoV-2 infection, and cellular immune responses contribute to protection against rechallenge with SARS-CoV-2. The findings suggest that relatively low antibody titres are sufficient for protection against SARS-CoV-2 in macaques, while higher antibody titres are required for treatment of SARS-CoV-2 infection.

NATURE (2021)

添加到收藏夹

Letter Clinical Neurology

The presence of SARS-CoV2 antibodies in MS patients

Asya I. Wallach et al.

Summary: An observational study found a high rate of low detection of antibodies in multiple sclerosis patients after COVID-19 infection, suggesting that certain disease-modifying therapies may impact antibody response or persistence.

MULTIPLE SCLEROSIS AND RELATED DISORDERS (2021)

添加到收藏夹

Article Immunology

Integrin Activation Enables Sensitive Detection of Functional CD4+ and CD8+ T Cells: Application to Characterize SARS-CoV-2 Immunity

Anna Schoellhorn et al.

Summary: This study introduces a modified assay for sensitive detection of functional antigen-specific CD4(+) T cells using a monoclonal antibody specific for the open, high-affinity conformation of the beta(2)-integrin. The assay allows simultaneous screening of both CD4(+) and CD8(+) T cell reactivities, with versatile applicability in clinical and vaccination studies. The novel assay enables very sensitive monitoring of effector and memory CD4(+) and CD8(+) T cells specific for various viruses in both whole blood and cryopreserved peripheral blood mononuclear cells (PBMCs).

FRONTIERS IN IMMUNOLOGY (2021)

添加到收藏夹

Article Multidisciplinary Sciences

COVID-19 severity and mortality in multiple sclerosis are not associated with immunotherapy: Insights from a nation-wide Austrian registry

Gabriel Bsteh et al.

Summary: This study investigated the prevalence and outcomes of COVID-19 in multiple sclerosis patients, and found that overall, exposure to disease-modifying treatment and immunosuppressive therapy were not significantly associated with COVID-19 outcomes, providing reassuring evidence for individual risk assessment in MS patients.

PLOS ONE (2021)

添加到收藏夹

Article Clinical Neurology

Infection Risks Among Patients With Multiple Sclerosis Treated With Fingolimod, Natalizumab, Rituximab, and Injectable Therapies

Gustavo Luna et al.

JAMA NEUROLOGY (2020)

添加到收藏夹

Letter Immunology

High-dimensional immune profiling by mass cytometry revealed immunosuppression and dysfunction of immunity in COVID-19 patients

Wenjing Wang et al.

CELLULAR & MOLECULAR IMMUNOLOGY (2020)

添加到收藏夹

Article Clinical Neurology

Interrupting rituximab treatment in relapsing-remitting multiple sclerosis; no evidence of rebound disease activity

Alexander Juto et al.

MULTIPLE SCLEROSIS AND RELATED DISORDERS (2020)

添加到收藏夹

Review Immunology

Immunology of COVID-19: Current State of the Science

Nicolas Vabret et al.

IMMUNITY (2020)

添加到收藏夹

Article Virology

Human Leukocyte Antigen Susceptibility Map for Severe Acute Respiratory Syndrome Coronavirus 2

Austin Nguyen et al.

JOURNAL OF VIROLOGY (2020)

添加到收藏夹

Article Allergy

Two X-linked agammaglobulinemia patients develop pneumonia as COVID-19 manifestation but recover

Annarosa Soresina et al.

PEDIATRIC ALLERGY AND IMMUNOLOGY (2020)

添加到收藏夹

Review Immunology

COVID-19 vaccine-readiness for anti-CD20-depleting therapy in autoimmune diseases

D. Baker et al.

CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2020)

添加到收藏夹

Article Clinical Neurology

Clinical Characteristics and Outcomes in Patients With Coronavirus Disease 2019 and Multiple Sclerosis

Celine Louapre et al.

JAMA NEUROLOGY (2020)

添加到收藏夹

Article Clinical Neurology

B-cell depleting therapies may affect susceptibility to acute respiratory illness among patients with multiple sclerosis during the early COVID-19 epidemic in Iran

Farinaz Safavi et al.

MULTIPLE SCLEROSIS AND RELATED DISORDERS (2020)

添加到收藏夹

Article Immunology

Phenotype and kinetics of SARS-CoV-2-specific T cells in COVID-19 patients with acute respiratory distress syndrome

Daniela Weiskopf et al.

SCIENCE IMMUNOLOGY (2020)

添加到收藏夹

Article Medicine, Research & Experimental

Severe immunosuppression and not a cytokine storm characterizes COVID-19 infections

Kenneth E. Remy et al.

JCI INSIGHT (2020)

添加到收藏夹

Article Biochemistry & Molecular Biology

Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19

Takuya Sekine et al.

CELL (2020)

添加到收藏夹

Article Clinical Neurology

COVID-19 in people with multiple sclerosis: A global data sharing initiative

Liesbet M. Peeters et al.

MULTIPLE SCLEROSIS JOURNAL (2020)

添加到收藏夹

Article Biochemistry & Molecular Biology

Humoral and circulating follicular helper T cell responses in recovered patients with COVID-19

Jennifer A. Juno et al.

NATURE MEDICINE (2020)

添加到收藏夹

Review Clinical Neurology

Neurological immunotherapy in the era of COVID-19-looking for consensus in the literature

Catharina Korsukewitz et al.

NATURE REVIEWS NEUROLOGY (2020)

添加到收藏夹

Article Clinical Neurology

Effect of ocrelizumab on vaccine responses in patients with multiple sclerosis The VELOCE study

Amit Bar-Or et al.

NEUROLOGY (2020)

添加到收藏夹

Letter Medicine, General & Internal

Rapid Decay of Anti-SARS-CoV-2 Antibodies in Persons with Mild Covid-19

F. Javier Ibarrondo et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

添加到收藏夹

Article Oncology

Could anti-CD20 therapy jeopardise the efficacy of a SARS-CoV-2 vaccine?

Roch Houot et al.

EUROPEAN JOURNAL OF CANCER (2020)

添加到收藏夹

Article Medicine, General & Internal

Efficacy of Tocilizumab in Patients Hospitalized with Covid-19

John H. Stone et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

添加到收藏夹

Review Immunology

Coronaviruses: Innate Immunity, Inflammasome Activation, Inflammatory Cell Death, and Cytokines

SangJoon Lee et al.

TRENDS IN IMMUNOLOGY (2020)

添加到收藏夹

Article Multidisciplinary Sciences

SARS-CoV-2 exposure, symptoms and seroprevalence in healthcare workers in Sweden

Ann-Sofie Rudberg et al.

NATURE COMMUNICATIONS (2020)

添加到收藏夹

Review Pharmacology & Pharmacy

Immunosuppressive Drugs and COVID-19: A Review

Tessa S. Schoot et al.

FRONTIERS IN PHARMACOLOGY (2020)

添加到收藏夹

Editorial Material Clinical Neurology

COVID-19 in 7 multiple sclerosis patients in treatment with ANTI-CD20 therapies

Virginia Meca-Lallana et al.

MULTIPLE SCLEROSIS AND RELATED DISORDERS (2020)

添加到收藏夹

Article Hematology

Waning of SARS-CoV-2 RBD antibodies in longitudinal convalescent plasma samples within 4 months after symptom onset

Josee Perreault et al.

BLOOD (2020)

添加到收藏夹

Review Multidisciplinary Sciences

Prognostic factors for severity and mortality in patients infected with COVID-19: A systematic review

Ariel Izcovich et al.

PLOS ONE (2020)

添加到收藏夹

Letter Clinical Neurology

Beyond COVID-19: DO MS/NMO-SD patients treated with anti-CD20 therapies develop SARS-CoV2 antibodies?

Elisabeth Maillart et al.

MULTIPLE SCLEROSIS AND RELATED DISORDERS (2020)

添加到收藏夹

Review Immunology

T Follicular Helper Cell Biology: A Decade of Discovery and Diseases

Shane Crotty

IMMUNITY (2019)

添加到收藏夹

Article Multidisciplinary Sciences

Therapeutic efficacy of dimethyl fumarate in relapsing-remitting multiple sclerosis associates with ROS pathway in monocytes

Karl E. Carlstrom et al.

NATURE COMMUNICATIONS (2019)

添加到收藏夹

Article Rheumatology

Effect of rituximab treatment on T and B cell subsets in lymph node biopsies of patients with rheumatoid arthritis

Tamara H. Ramwadhdoebe et al.

RHEUMATOLOGY (2019)

添加到收藏夹

Article Multidisciplinary Sciences

IL-17+ CD8+ T cell suppression by dimethyl fumarate associates with clinical response in multiple sclerosis

Christina Lueckel et al.

NATURE COMMUNICATIONS (2019)

添加到收藏夹

Article Multidisciplinary Sciences

Activated integrins identify functional antigen-specific CD8+ T cells within minutes after antigen stimulation

Stoyan Dimitrov et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)

添加到收藏夹

Article Biochemistry & Molecular Biology

Memory B Cells Activate Brain-Homing, Autoreactive CD4+ T Cells in Multiple Sclerosis

Ivan Jelcic et al.

CELL (2018)

添加到收藏夹

Article Medicine, General & Internal

Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis

X. Montalban et al.

NEW ENGLAND JOURNAL OF MEDICINE (2017)

添加到收藏夹

Review Medicine, General & Internal

Memory B Cells are Major Targets for Effective Immunotherapy in Relapsing Multiple Sclerosis

David Baker et al.

EBIOMEDICINE (2017)

添加到收藏夹

Article Rheumatology

Rituximab therapy reduces activated B cells in both the peripheral blood and bone marrow of patients with rheumatoid arthritis: depletion of memory B cells correlates with clinical response

Magda Nakou et al.

ARTHRITIS RESEARCH & THERAPY (2009)

添加到收藏夹

Article Multidisciplinary Sciences

Promotion of lymphocyte egress into blood and lymph by distinct sources of sphingosine-1-phosphate

Rajita Pappu et al.

SCIENCE (2007)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.